Almut Winterstein, Ph.D., a professor and the Dr. Robert and Barbara Crisafi Chair of Pharmaceutical Outcomes and Policy in the University of Florida College of Pharmacy, has been named president-elect of the International Society for Pharmacoepidemiology, or ISPE. She was installed on Aug. 25, at the ISPE Annual Conference in Prague, Czech Republic.
As president-elect, Winterstein will serve on the executive board and chair the strategic planning committee. The committee will be developing a new strategic plan and overseeing a grants program that funds manuscripts relevant to ISPE’s mission. She will take over as president of the organization in August 2019, when ISPE’s membership meets in Philadelphia.
Winterstein joined ISPE in 2000 and has held numerous leadership roles during the past two decades. She has served on the ISPE education committee since 2008. In 2011-12, she chaired the academic council and was a member of the board of directors from 2014-17. Twice, she has served on scientific programming committees for ISPE meetings.
ISPE is dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy, education, and advocacy for the field of pharmacoepidemiology, including such area as pharmacovigilance, drug utilization research, comparative effectiveness review, and therapeutic risk management. ISPE members represent the various scientific disciplines involved in studying drugs. Members are employed by the pharmaceutical industry, academic institutions, government agencies, non-profit and for-profit private organizations. Members have degrees in a number of fields, including epidemiology, biostatistics, medicine, nursing, pharmacology, pharmacy, law, health economics, and journalism. With members in 53 countries, ISPE provides an international forum for sharing knowledge and scientific approaches to foster the science of pharmacoepidemiology.